Feb 21 (Reuters) - Genetic testing firm 23andMe ME.O Chief Executive Officer Anne Wojcicki and investment firm New Mountain Capital have submitted a proposal to take the company private, according to a regulatory filing on Friday.
Both parties have jointly made an offer to buy the company for $2.53 per share, a deal that would value the company at $67.9 million.
Last month, 23andMe had said it was exploring strategic alternatives, including a possible sale, in light of significant doubts about its ability to sustain operations.
Wojcicki, who has been trying to take the company private since April, has faced a tough challenge after independent directors of 23andMe resigned in September, unsatisfied with the take-private offer they received.
In July, the CEO and co-founder proposed buying all outstanding shares of the firm not already owned by her or affiliated entities for 40 cents each.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
((Christy.Santhosh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。